EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Functional single-cell omics in gynecological cancers immunotherapy: from heterogeneity dissection to clinical translation

Dong-Mei Li, Kai-Ge Pei, Bo-Wen Yang, Ming-Rong Qie, Jin-Feng Xu, Lan Zhong, Liang Song

Frontiers in Immunology · 2026

DOI: 10.3389/fimmu.2026.1981010 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Immunology, 2026. Verfasst von Dong-Mei Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Single-Cell Analysis, Immunotherapy, Genital Neoplasms, Female. Die Arbeit nennt 125 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ovarian, endometrial, and cervical cancers represent major threats to women’s health worldwide. The profound heterogeneity of their immune microenvironments has rendered immune checkpoint blockade (ICB) therapies, particularly PD-1/PD-L1 inhibitors, far less effective than anticipated in gynecological malignancies. Conventional research approaches, constrained by coarse analytical resolution, are insufficient to unravel the underlying mechanisms of this therapeutic shortfall. Functional single-cell omics technologies, including single-cell RNA sequencing, single-cell chromatin accessibility profiling, spatial transcriptomics, and multi-omics integration, have provided a new framework for systematically studying the tumor immune microenvironment across three progressive dimensions: cellular identity, functional state, and spatial localization. This review systematically synthesizes the applications of this technological toolkit in the three major gynecological cancers. It reveals distinct bottlenecks across the three dimensions. In ovarian cancer, the core obstacle lies in the spatial dimension, where cancer-associated fibroblast-mediated physical barriers and pro-angiogenic macrophage subsets together construct a “spatial exclusion” microenvironment. In cervical cancer, the principal bottleneck resides in the functional dimension, where HPV status and histological subtype drive a “functional disability” phenotype, in which T cells infiltrate but fail to achieve effective activation, with therapy resistance-associated immune evasion clones further exacerbating functional impairment. In endometrial cancer, however, the immune fate is governed by the identity dimension, where molecular subtypes dictate the baseline nature of immune infiltration, and autophagy-related cellular subpopulations may offer new insights into intratumoral heterogeneity. Although single-cell omics has identified immunologically actionable targets with translational potential, including TREM2 + macrophages and the LAG-3/TIM-3 dual-target axis, clinical translation remains constrained by technical and biological bottlenecks, including stringent requirements for tissue sample quality, high assay costs, lack of standardized analytical pipelines, and the discordance between transcriptomic profiles and protein-level functionality.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Single-Cell AnalysisImmunotherapyGenital Neoplasms, FemaleHumansFemaleMultiomicsTumor MicroenvironmentTranslational Research, BiomedicalSingle-Cell Gene Expression AnalysisAnimalsSpatial Transcriptomics

Stichwörter der Autor:innen

T cellsTILsgynecological cancerimmunotherapysingle-cell omics

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, Chengdu, China.
  • Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, China.
  • Department of Medical Oncology, West China Second University Hospital, Sichuan University, Chengdu, China.

Zitieren

APA

Li, D. M., Pei, K. G., Yang, B. W., Qie, M. R., Xu, J. F., Zhong, L., & Song, L. (2026). Functional single-cell omics in gynecological cancers immunotherapy: from heterogeneity dissection to clinical translation. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2026.1981010

Vancouver

Li DM, Pei KG, Yang BW, Qie MR, Xu JF, Zhong L, et al. Functional single-cell omics in gynecological cancers immunotherapy: from heterogeneity dissection to clinical translation. Frontiers in Immunology. 2026. doi:10.3389/fimmu.2026.1981010

BibTeX
@article{Li2026,
  author = {Li, Dong-Mei and Pei, Kai-Ge and Yang, Bo-Wen and Qie, Ming-Rong and Xu, Jin-Feng and Zhong, Lan and Song, Liang},
  title = {Functional single-cell omics in gynecological cancers immunotherapy: from heterogeneity dissection to clinical translation},
  journal = {Frontiers in Immunology},
  year = {2026},
  doi = {10.3389/fimmu.2026.1981010}
}
Kostenlos starten →